From July 1, 2022 to August 7, 2022, the company has repurchased 1,992,600 shares, representing 0.12% for CNY 20.05 million. With this, the company has completed the repurchase of 4,187,406 shares, representing 0.26% for CNY 40.05 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.59 CNY | -2.72% | -4.56% | -15.95% |
25/04 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/03 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.95% | 197.57Cr | |
+2.74% | 9.42TCr | |
-3.42% | 3.78TCr | |
-13.75% | 3.25TCr | |
+73.19% | 2.78TCr | |
-11.88% | 1.61TCr | |
+0.49% | 1.42TCr | |
-12.95% | 1.14TCr | |
+190.36% | 1.11TCr | |
-54.07% | 908.81Cr |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.